RemeGen Co. Ltd. Class A RemeGen Co. Ltd. Class A

RemeGen Co. Ltd. Class A

688331

Classifica tra le azioni #2326
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces,... RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
Prezzo delle azioni
$15.25
Capitalizzazione di mercato
$8.54B
Variazione (1 giorno)
5.24%
Variazione (1 anno)
11.87%
Paese
CN
Scambia RemeGen Co. Ltd. Class A (688331)

Categoria

Healthcare
Storico del prezzo dell'azione per RemeGen Co. Ltd. Class A (688331)
Prezzo di chiusura più alto: $15.01 il 2026-10-01

Prezzo di chiusura più basso: $6.44 il 2022-03-01
Storico del prezzo dell'azione di RemeGen Co. Ltd. Class A dal 2022 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 33.49%
2025 157.04%
2024 -48.44%
2023 -13.90%
2022 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.18 23.67%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $251.29 814.11%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $138.33 -3.31%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $890.85 6.72%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $752.87 7.40%
CH